J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 70 (1989), 429-434; DOI 10.1099/0022-1317-70-2-429
© 1989 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Correction (v70,p2539)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prevec, L.
Right arrow Articles by Graham, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prevec, L.
Right arrow Articles by Graham, F. L.
Agricola
Right arrow Articles by Prevec, L.
Right arrow Articles by Graham, F. L.

Use of Human Adenovirus-based Vectors for Antigen Expression in Animals

L. Prevec1,2,, M. Schneider1, K. L. Rosenthal2, L. W. Belbeck2, J. B. Derbyshire3 and F. L. Graham1,2,

1 Department of Biology
and2 Pathology, McMaster University, Hamilton, Ontario, Canada L8S 4K1
and3 Department of Veterinary Microbiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1

An infectious recombinant human adenovirus type 5 (Ad5) vector, AdG12, which carries the glycoprotein gene of vesicular stomatitis virus (VSV) and expresses that gene in cultured HeLa cells was used to examine the host range of insert expression by human Ad vectors. The VSV glycoprotein was expressed in bovine, canine and murine cells when infected with AdG12 in culture. These cell lines are respectively permissive, non-permissive and semi-permissive for human Ad5 replication. Administration of the AdG12 vector to calves, piglets or dogs by either the subcutaneous or oral route resulted in the production of high titres of neutralizing antibodies to VSV. Mice injected intraperitoneally with the vector produced neutralizing antibodies and were protected against subsequent intravenous challenge with normally lethal doses of VSV. This work demonstrates the utility of human adenoviral vectors for antigen expression in a number of non-human cell lines and for the induction of an immune response to the delivered antigen in a number of species.

Keywords: adenovirus, vectors, VSV

Received 26 July 1988; accepted 18 October 1988.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
H. M. Vordermeier, B. Villarreal-Ramos, P. J. Cockle, M. McAulay, S. G. Rhodes, T. Thacker, S. C. Gilbert, H. McShane, A. V. S. Hill, Z. Xing, et al.
Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis
Infect. Immun., August 1, 2009; 77(8): 3364 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. M. Gherardi and M. Esteban
Recombinant poxviruses as mucosal vaccine vectors
J. Gen. Virol., November 1, 2005; 86(11): 2925 - 2936.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. J. Grubman and B. Baxt
Foot-and-Mouth Disease
Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Friedman and M. S. Horwitz
Inhibition of Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activation by the Adenovirus E3-10.4/14.5K Complex
J. Virol., May 3, 2002; 76(11): 5515 - 5521.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. S. Reddy, N. Idamakanti, L. A. Babiuk, M. Mehtali, and S. K. Tikoo
Porcine adenovirus-3 as a helper-dependent expression vector
J. Gen. Virol., November 1, 1999; 80(11): 2909 - 2916.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
A. Zakhartchouk, C Pyne, G. Mutwiri, Z Papp, M. Baca-Estrada, P Griebel, L. Babiuk, and S. Tikoo
Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1
J. Gen. Virol., May 1, 1999; 80(5): 1263 - 1269.
[Abstract]


Home page
J. Gen. Virol.Home page
A Sanz-Parra, B Vazquez, F Sobrino, S. Cox, V Ley, and J. Salt
Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins
J. Gen. Virol., March 1, 1999; 80(3): 671 - 679.
[Abstract]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Ilan, G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz
Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression
PNAS, March 18, 1997; 94(6): 2587 - 2592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Takahashi, Y. Ilan, N. R. Chowdhury, J. Guida, M. Horwitz, and J. R. Chowdhury
Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period
J. Biol. Chem., October 25, 1996; 271(43): 26536 - 26542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1989 by the Society for General Microbiology.